KMT2A and acute myeloid leukemia: A CCK-8 assay revealed that primary MLL-AF9 AML cells co-cultured with Mettl3 knockout BMMSCs exhibited reduced sensitivity to the chemotherapeutic drugs Ara-C and DNR (Fig. 3A).